FMW Media's New To The Street / Newsmax TV show announces the
broadcasting line-up of its national syndicated 1-hour TV show this
Sunday, June 26, 2022, airing time 10-11 AM ET.
New to The Street’s 358th TV show line-up,
features six (6) interviews of the following Companies and their
representatives:
1). Tonix Pharmaceuticals, Inc.'s (NASDAQ:
TNXP) interview with Dr. Seth Lederman, MD, and CEO.
2). Sun West Mortgage Company, Inc.'s interview
with Mr. Pavan Agarwal, CEO
3). PetVivo Holdings, Inc.'s (NASDAQ: PETV)
(NASDAQ: PETVW) interview with Mr. Mark Middleton, National Sales
Director.
4). Sekur Private Data, Ltd.'s (OTCQX: SWISF)
(CSE: SKUR) (FRA: GDT0) interview with Mr. Alain Ghiai, CEO.
5). Smile Design Manhattan’s interview with Dr.
Lee Gause, DDS, and CEO.
6). “Weekly Sekur Privacy & Sekur
Security Segment” interview with internet privacy expert
Mr. Alain Ghiai, CEO, Sekur Private Data Ltd. (OTCQX: SWISF) (CSE:
SKUR) (FRA: GDT0) (Sekur®)
New to The Street TV re-airs Dr. Seth Lederman,
MD, CEO at Tonix Pharmaceuticals, Inc. (NASDAQ: TNXP),
in-studio interview at the Nasdaq Marketplace with TV Host Jane
King. Recently, TNXP released data during three oral presentations
at the 2022 American Transplant Congress held at the Center of
Transplantation Sciences, Massachusetts General Hospital. TNX-1500
sees exciting results as a therapy in eliminating transplant
rejections in the heart and kidneys. Through a collaboration with
Massachusetts General Hospital, part of the Harvard Medical School,
the TNX-1500 shows data for possible product development for
therapeutic prevention of organ transplant rejection. TNX-1500
shows exciting results to date. A particular molecule, CD40-ligand
(CD40L), appears to be the reason for transplant rejections. TNXP
engineered a monotherapy to block toxicities associated with CD40L;
its TNX-1500 in animal studies shows activities to prevent
rejections. Dr. Lederman talks about the monkeypox virus and
compares the West African and Central African variants. The West
African is the one the press reports about, with infections
worldwide not appearing deadly. The Central African variant, with
no reported cases, can be lethal. TNXP has two patented vaccines,
one for smallpox and the other for monkeypox. TNX-801 is a
horsepox-based live virus vaccine currently in development to
protect against monkeypox and smallpox. The monkeypox vaccine is
in-testing with lab monkeys; so far, results look promising in
possible prevention. The Company's fibromyalgia and Long-COVID
studies and clinical trials continue at TNXP. Exciting times for
the Company for their novel therapies and treatments; Dr. Lederman
will come back on a future show with further updates. The on-screen
QR code is available during the show; download or visit Tonix
Pharmaceuticals, Inc. - https://www.tonixpharma.com/. This
interview segment initially aired on June 19, 2022.
New to The Street’s TV Host Jane King welcomes Mr.
Pavan Agarwal, CEO at Sun West Mortgage Company, Inc. For over 40
years, the Sun West Mortgage Company has offered mortgages for the
low to mid-income earners throughout the US and Caribbean. Pavan
passionately describes the quality of care that Sun West gives
every mortgage applicant. After years of development, The Company
rolled-out its Morgan™ platform, a technology-driven AI platform
that understands and appreciates the unique challenges of getting a
mortgage. As the first of its kind in the marketplace, the Morgan
platform is an empathetic technology that offers solutions that
intelligently adapt to a mortgage applicant's individual needs,
situations, and state of mind. Each loan officer and executive at
Sun West takes a human-to-human approach to each applicant,
ensuring everyone is fairly and kindly treated. The Morgan platform
takes artificial intelligence and creates a human-to-technology
interaction during the home buying process, eliminating stress,
anxiety, uncertainty, and risk, even for those with challenging
credit and employment history. Fair lending and fair equality are a
must at Sun West Mortgage. Pavan says you cannot have one without
the other, and his team, along with the Morgan™ mortgage platform,
commit themselves to each applicant with need-based compassion. You
are not just a number and a credit score; each applicant has unique
life issues, and Sun West Mortgage Company wants to understand each
applicant's needs. The on-screen QR code is available during the
show; download or visit Sun West Mortgage Company, Inc. -
https://www.swmc.com/.
A second airing on New to The Street TV is Mr.
Mark Middleton, National Sales Director at PetVivo Holdings,
Inc. (NASDAQ: PETV) (NASDAQ: PETVW), and TV Host Jane King,
who talks about the Company and its products. PetVivo Holdings,
Inc. is a biomedical device company that manufactures,
commercializes, and licenses innovative medical devices and
therapeutics for companion animals. As PETV's National Sales
Director, Mark talks about his history within the pet products
industry, dealing with FDA manufacturing, product distributions,
capital markets, and mergers/acquisitions. He sees himself as a
perfect fit at PETV; he understands the veterinarians (DVMs) needs
for best practices and product result outcomes for their clients'
animals. The injectable patented Spryng with OsteoCushion
Technology treats osteoarthritis and joint afflictions while
providing rehabilitation treatments for horses and dogs and
continues to grow as a reliable DVM treatment. Being an
entirely naturally derived product, Spryng is superior to
competitors' non-biological, synthetic products, and the Spryng
treatment lasts longer. The PETV has a talent team who understands
science, finance, sales/marketing, manufacturing, distribution,
etc. With patience, persistence, and follow-through, Mark sees a
strong future for PETV. The on-screen QR code is available during
the show; download or visit PetVivo Holdings,
Inc. - https://petvivo.com/ and Spryng with
OsteoCushion Technology -
https://www.sprynghealth.com/. This interview segment initially
aired on June 5, 2022.
New to The Street TV airs the in-studio interview
at the Nasdaq Marketplace with Mr. Alain Ghiai, CEO
at Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA:
GDT0). Talking with TV Host Jane King, Alain explains the
workplace dynamic that shifted to a hybrid work schedule where
workers work partially at home and office. While at home, employees
log on to corporate systems using less secure home connections.
Hackers exploit these home systems, creating a hacking portal into
corporate IT networks. Alain states that over $6T in economic
losses occur worldwide on data hacks, and his Company’s Sekur
products can help eliminate data breaches. He explains the
Company's newest encrypted product, "Chat-by-Invite." This new tool
gives subscribers an utterly private communication. It works when
the Sekur subscriber sends a text or email message to a
recipient, and a link appears that opens into a private, secure
platform hosted in Switzerland. Essentially, the chat occurs on the
Swiss servers owned and controlled by Sekur Private Data, Ltd. At
the end of a transmission, the initiator can remotely terminate the
communication and delete all traces, including the recipient’s
post. Hackers won't know about the transmission because of the
highly encrypted military technology behind the product. There is
no direct texting on open-source platforms, making them
invulnerable to cybersecurity breaches. The SekurMail /
SekurMessenger, SekurVoice, SekurProVideo Conference, and
other products are available now or soon. Sekur's "Chat-by-Invite"
app is available on iOS and Android; go to Sekur.com to
download it. Subscribers get cybersecurity protections not
available with open-source programs for reasonable pricing. Domain
migration for emails is available for individuals and businesses.
Alain invites viewers to the tutorial videos on how the products
work. The Company recently uplifted its share onto the OTCQX
trading platform at OTCMarkets, and Alain explains the Company's
goal in getting its share trading on a US national stock exchange.
The Company, with its recurring revenues month over month from
service subscribers, no debt, no toxic finances, and money in the
bank, the value proposition for any investor looks attractive. As
an added protection to subscribers, Sekur Private Data, Ltd
operates its internet platforms and security businesses under the
country of Switzerland's very tough privacy laws. The on-screen QR
code is available during the show to download more info or visit
Sekur Private Data, Ltd. – http://www.Sekur.com.
The in-studio interview at the Nasdaq
Marketplace with Smile Design Manhattan’s CEO, Dr. Lee Gause, DDS,
is re-airing on this week’s New to The Street show. Talking with
New to The Street TV’s Host Jane King, Dr. Gause explains the
“Smile 23” platform that ensures that business executives make the
most impressive physical appearance during presentations. A smile
can make all the difference when talking with others, and Dr. Gause
says that a warm, inviting smile can build huge confidence for the
presenter and those attending in-person or Zoom presentations.
“Smile 23” looks to roll up many high-end dental practices with a
high level of care, positive patient experiences, and
technologically advanced locations. More than 80% of the population
is missing at least one tooth. Dental implant growth and technology
advancements can reduce cost and improve service quality. The
advent of robotic technology in other medical fields is now
migrating into dental offices. The dentist-controlled robots can
assist in precise dental implants. Dr. Gause talks about “Zoom Call
Anxiety,” a condition when someone worries about their appearance
on a video chat. With single dental implants costing an average of
$5,000, Dr. Gause sees cost lowering and care access increasing.
Smile Design Manhattan can provide video consultation, and with its
“Smile 23” platform, you can get that smile you always wanted. The
on-screen QR code is available during the show; download or visit
Smile Design Manhattan - https://www.smiledesignmanhattan.com/.
This interview segment initially aired on June 5, 2022.
New to the Street TV re-airs its “Weekly
Sekur Privacy & Sekur Security
Segment” with internationally acclaimed
internet privacy expert Mr. Alain Ghiai, CEO at Sekur Private Data
Ltd. (OTCQX: SWISF) (CSE: SKUR) (FRA: GDT0) and TV Host /
Multi-media Journalist Ana Berry. Ana opens the show talking about
receiving electronic communication from the Oklahoma State
Department of Health on steps to take to prevent being cyber-hacked
during vacation travels. The state recommended several suggestions,
including checking your device’s settings, installing up-to-date
software, and changing passwords. Alain agreed with these
suggestions and complimented the State of Oklahoma for being
proactive. A common issue is that the factory setting is put back
as default when downloading a new version of an updated app or
software. Alain says these settings are advantageous for the app
and software data harvesting. After new and updated app downloads,
Alain suggests you go into your setting feature and enable all
privacy settings, which can eliminate potential spying of your
devices. Turn off your location settings on your mobile devices and
only use them when necessary for a particular app when needed. An
Uber lawsuit awarded damages for unauthorized sharing of location
data and developed an industry-wide acceptance of a feature that
now notifies end-users of permission-based options. End-users can
directly agree or disagree with sharing their data when downloading
apps. A password generation program is good to use. Alain, however,
recommends using a sentence as your password with upper- and
lower-case letters, numbers, and special characters; 8 or more
characters is a must for a password. Update passwords every 90-days
is a good idea to further protect from a possible hack. Alain
suggests not using “Free” Wi-Fi at hotels, restaurants, airports,
stores, etc., because open portals are prone to hacking data. Sekur
Private Data, Ltd, based in Switzerland, uses its Helix
military-grade encryption platform to develop many Sekur products
that provide secure and private electronic communications. Emails,
text messages, and domain migration are available as
subscription-based services. SekurVPN (Virtual Private Network), a
new product available soon, gives a single location VPN in
Switzerland. Competitor products offer different VPN links based on
your location. Having multiple VPNs switching back and forth from
place to place can be a possible cybersecurity problem. Hosted in
Switzerland, the SekurVPN network is available no matter where you
connect. Alain recommends viewers learn more about Sekur products
by going to the video tutorials on the Company’s website -
https://sekur.com/en/tutorials. For over 1-year now, the
“Weekly Sekur Privacy & Sekur Security
Segment” provides excellent tips and education on
preventing businesses and individuals with potential cybersecurity
threats and hacks. Each week, the segment continues forward, and
viewers can proactively learn more ways to avoid data breaches. The
on-screen QR code is available during the show; download or visit
Sekur Private Data, Ltd. – http://www.Sekur.com. “What is
your privacy worth?” This interview segment initially
aired on June 19, 2022.
About Tonix Pharmaceuticals Holding Corp.
(NASDAQ: TNXP):
Tonix Pharmaceuticals Holding Corp. (NASDAQ:
TNXP) is a clinical-stage biopharmaceutical company focused on
discovering, licensing, acquiring, and developing small molecules
and biologics to treat and prevent human disease and alleviate
suffering. Tonix's portfolio comprises immunology, rare disease,
infectious disease, and central nervous system (CNS) product
candidates. Tonix's immunology portfolio includes biologics to
address organ transplant rejection, autoimmunity, and cancer.
TNX-15001 is a humanized monoclonal antibody targeting CD40-ligand
in development to prevent allograft and xenograft rejection and
treat autoimmune diseases. A Phase 1 study of TNX-1500 is expected
to be initiated in the second half of 2022. Tonix's rare disease
portfolio includes TNX-29002 for the treatment of Prader-Willi
syndrome. The FDA has granted TNX-2900 Orphan-Drug Designation.
Tonix's infectious disease pipeline consists of a vaccine in
development to prevent smallpox and monkeypox called TNX-8013,
next-generation vaccines to prevent COVID-19, and an antiviral to
treat COVID-19. Tonix's lead vaccine candidates for COVID-19 are
TNX-1840 and TNX-18504, live virus vaccines based on Tonix's
recombinant pox vaccine (RPV) platform. TNX-35005
(sangivamycin, i.v. solution) is a small molecule
antiviral drug to treat acute COVID-19 and is in the pre-IND stage
of development. TNX-102 SL, (cyclobenzaprine HCl sublingual
tablets) is a small molecule drug being developed to treat Long
COVID, a chronic post-acute COVID-19 condition. Tonix expects to
initiate a Phase 2 study in Long COVID in the second quarter of
2022. The Company's CNS portfolio includes small molecules and
biologics to treat pain, neurologic, psychiatric and addiction
conditions. Tonix's lead CNS candidate, TNX-102 SL, is in mid-Phase
3 development to manage fibromyalgia, with a new Phase 3 study
launched in the second quarter of 2022. Finally, TNX-13006 is a
biologic designed to treat cocaine intoxication that is expected to
start a Phase 2 trial in the second quarter of 2022
- https://www.tonixpharma.com. (1TNX-1500 is an
investigational new biologic at the pre-IND stage of development
and has not been approved for any indication.2TNX-2900 is an
investigational new drug at the pre-IND stage of development and
has not been approved for any indication.3TNX-801 is a live
horsepox virus vaccine for percutaneous administration in
development to protect against smallpox and monkeypox. TNX-801 is
an investigational new biologic and has not been approved for any
indication.4TNX-1840 and TNX-1850 are live horsepox virus vaccines
for percutaneous administration, in development to protect against
COVID-19. TNX-1840 and TNX-1850 are designed to express the
SARS-CoV-2 spike protein from the omicron and BA.2 variants,
respectively. TNX-1840 and TNX-1850 are investigational new
biologics at the pre-IND stage of development and have not been
approved for any indication. 5TNX-3500 is an investigational new
drug at the pre-IND stage of development and has not been approved
for any indication.6TNX-1300 is an investigational new biologic and
has not been approved for any indication.)
About Sun West Mortgage Company,
Inc.:
Sun West Mortgage Company, Inc. dedicates itself
to offering its customers the best service. To accomplish this,
they empower their loan officers so that they can find great rates
and provide the most appropriate loan options for each customer –
at amazing speed. The Company focuses on technology, giving them an
edge in the mortgage industry to offer some of the fastest turn
times available – so the customer can get into the home of their
dreams sooner. They commit to their core values of people,
experience, technology, and product. Sun West's Morgan™ platform is
a technology and AI platform that understands and appreciates the
unique challenges of getting a mortgage. The platform is available
24 hours & 7 days a week. It was created to intuitively
understand simple and complex requests and gives end-users a
context-aware resolution of all daily requests, thereby resolving
challenges with rigorous efficiency. The Morgan platform provides
any inquiry, assistance, or service that an end-user require is
completed intuitively, in minutes, and without friction. Founded in
1980, Sun West services a multi-billion-dollar loan portfolio with
the perspective of "customers first" and the desire to make the
mortgage process easy and stress-free for prospective homeowners.
Licensed in 48 states, the District of Columbia, Puerto Rico, and
the US Virgin Islands, Sun West Mortgage Company, Inc. acts as the
lender and offers to finance qualified borrowers -
https://www.swmc.com/ & https://www.hellomorgan.com/.
About PetVivo Holdings, Inc. (NASDAQ:
PETV) (NASDAQ: PETVW):
PetVivo Holdings, Inc. (NASDAQ: PETV)
(NASDAQ: PETVW) is an emerging biomedical device company currently
focused on manufacturing, commercializing, and licensing innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies to treat
companion animals time-efficiently and less costly. A key component
of this strategy is the accelerated timeline to revenues for
veterinary medical devices that enter the market much earlier than
more stringently regulated pharmaceuticals and biologics. PetVivo
has a pipeline of seventeen products to treat animals and people. A
portfolio of nineteen patents protects the Company's biomaterials,
products, production processes, and use methods. The Company's lead
product Spryng with OsteoCushion Technology, a
veterinarian-administered, intraarticular injection to treat
lameness and other joint-related affliction, including
osteoarthritis, in dogs and horses, is currently available for
commercial sale to veterinarians
- https://petvivo.com/ & https://www.sprynghealth.com/.
About Smile Design
Manhattan:
Smile Design Manhattan’s goal for its dentists,
endodontists and dental hygienists is to provide high-quality oral
health care to men and women living in and around Midtown West, New
York City. Patients feel confident about oral hygiene care and
results when the dentist and office staff reiterate clear
communications and a commitment to individualized care. At Smile
Design Manhattan, the team’s commitment to patient comfort and
cutting-edge technology extends to all the clinical treatment
areas. The providers at Smile Design Manhattan provide a different
kind of dental experience. After hearing dozens of new patients
tell of “nightmare” dental scenarios, Smile Design Manhattan
founder Lee Gause, DDS, designed the practice’s environments to be
warm and inviting. Patients can access the best, most comprehensive
oral health care and partner with the team at Smile Design
Manhattan - https://www.smiledesignmanhattan.com/.
About Sekur Private Data Ltd. (OTCQX:
SWISF) (CSE: SKUR) (FRA: GDT0):
Sekur Private Data, Ltd. (OTCQX: SWISF) (CSE:
SKUR) (FRA: GDT0) is a Cybersecurity and
Internet privacy provider of Swiss hosted solutions for secure
communications and secure data management. The Company distributes
encrypted emails, secure messengers, secure communication tools,
secure cloud-based storage, disaster recovery, and document
management products. The Company sells and serves consumers,
businesses, and governments worldwide through approved wholesalers,
distributors, and telecommunications companies. Contact Sekur
Private Data, Ltd. at corporate@globexdatagroup.com or
visit https://www.sekurprivatedata.com and https://www.sekur.com.
About FMW Media:
FMW Media operates one of the longest-running US
and International sponsored and Syndicated Nielsen Rated
programming TV brands, "New to The Street" and its blockchain show
"Exploring The Block." Since 2009, these brands have run
biographical interview segment shows across major U.S. Television
networks. The paid-for-TV programming platforms can potentially
reach over 540 million homes in the US and international markets.
FMW's New to The Street / Newsmax TV broadcasting platform airs its
syndication on Sundays at 10 -11 AM ET. FMW is also one of the
nation's largest buyers of linear television, long and short-form
paid programming
- https://www.newsmaxtv.com/Shows/New-to-the-Street & https://www.newtothestreet.com/.
Forward-Looking Statements
Disclaimer:
This press release contains forward-looking
statements within Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934. In
some cases, you can identify forward-looking statements by the
following words: "anticipate," "believe," "continue," "could,"
"estimate," "expect," "intend," "may," "ongoing," "plan,"
"potential," "predict," "project," "should," "will," "would," or
the negative of these terms or other comparable terminology.
However, not all forward-looking statements contain these words.
Forward-looking statements are not a guarantee of future
performance or results and will not necessarily be accurate
indications of the times at which such performance or results are
achieved. This press release should be considered in all filings of
the Companies contained in the Edgar Archives of the Securities and
Exchange Commission at www.sec.gov.
CONTACT:
FMW Media Contact:
Bryan Johnson +1 (631) 766-7462
Bryan@NewToTheStreet.com
"New to The Street" Business Development Office
1-516-696-5900 Support@NewtoTheStreet.com
A photo accompanying this announcement is
available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/e348e2c6-20a0-4a2a-a16d-e72a6948f36c
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2024 to Jul 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Jul 2023 to Jul 2024